Page last updated: 2024-10-23

astemizole and Experimental Neoplasms

astemizole has been researched along with Experimental Neoplasms in 2 studies

Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.

Research Excerpts

ExcerptRelevanceReference
"Astemizole was administered with the food to mice for 18 and to rats for 24 consecutive months."1.29Carcinogenicity studies of astemizole in mice and rats. ( Benze, J; Bowden, C; De Coster, R; Gypen, L; Lampo, A; Van Cauteren, H; Vandenberghe, J, 1995)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benze, J1
Gypen, L1
Vandenberghe, J1
Lampo, A1
De Coster, R1
Bowden, C1
Van Cauteren, H1

Other Studies

2 other studies available for astemizole and Experimental Neoplasms

ArticleYear
Carcinogenicity studies of astemizole in mice and rats.
    Cancer research, 1995, Dec-01, Volume: 55, Issue:23

    Topics: Aging; Animals; Astemizole; Carcinogenicity Tests; Dose-Response Relationship, Drug; Female; Histami

1995
Ambivalent antihistamines.
    Environmental health perspectives, 1994, Volume: 102, Issue:11

    Topics: Animals; Astemizole; Carcinogens; Histamine H1 Antagonists; Hydroxyzine; Loratadine; Mice; Neoplasms

1994